Determinants of enrollment in a preventive HIV vaccine trial: Hypothetical versus actual willingness and barriers to participationBUCHBINDER, Susan P; METCH, Barbara; HOLTE, Sarah E et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 36, Num 1, pp 604-612, issn 1525-4135, 9 p.Article

Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in womenABDOOL KARIM, Salim S; RICHARDSON, Barbra A; MOENCH, Thomas R et al.AIDS (London). 2011, Vol 25, Num 7, pp 957-966, issn 0269-9370, 10 p.Article

HIV incidence among women of reproductive age in Malawi and ZimbabweKUMWENDA, Newton; HOFFMAN, Irving; ROSENBERG, Zeda et al.Sexually transmitted diseases. 2006, Vol 33, Num 11, pp 646-651, issn 0148-5717, 6 p.Article

Safety and acceptability of the Reality condom for anal sex among men who have sex with menRENZI, Cristina; TABET, Stephen R; STUCKY, Jason A et al.AIDS (London). 2003, Vol 17, Num 5, pp 727-731, issn 0269-9370, 5 p.Article

Randomized, controlled evaluation of a prototype informed consent process for HIV Vaccine efficacy TrialsCOLETTI, Anne S; HEAGERTY, Patrick; SHEON, Amy R et al.Journal of acquired immune deficiency syndromes (1999). 2003, Vol 32, Num 2, pp 161-169, issn 1525-4135, 9 p.Article

Safety and acceptability of penile application of 2 candidate topical microbicides: BufferGel and PRO 2000 Gel 3: Randomized trials in healthy low-risk men and HIV-positive menTABET, Stephen R; CALLAHAN, Marianne M; WALSH, Terri L et al.Journal of acquired immune deficiency syndromes (1999). 2003, Vol 33, Num 4, pp 476-483, issn 1525-4135, 8 p.Article